A 35-year-old lady was diagnosed with a left-sided breast cancer (infiltrating ductal carcinoma, grade 2, estrogen receptor/progesterone receptor positive, human epidermal growth factor receptor 2 negative). She received neoadjuvant anthracycline-based chemotherapy, followed by breast conserving surgery. Postoperatively she commenced weekly paclitaxel 80 mg/m^2^/week. After the 8^th^ dose, she presented with painful swelling of hands, feet and a bilateral symmetrical rash over the extensor surfaces of legs up to the knees-ill-defined macules, papules and pustules with surrounding erythema \[Figures [1a](#F1a){ref-type="fig"} and [b](#F1b){ref-type="fig"}\]. She improved with a 5-day course of low dose oral prednisolone and an oral antibiotic. Chemotherapy was terminated and she was started on adjuvant tamoxifen.
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